Plaque psoriasis can also affect the scalp ... Eczema tends to run in families, especially in those prone to allergies and asthma. About half of children diagnosed with eczema also will develop ...

A person with plaque psoriasis breaks out in a rash that most ... underlying genetic and environmental factors. Food allergies, asthma, and allergic rhinitis are often linked with eczema.

Late-breaking data supported the efficacy of icotrokinra, an interleukin-23 inhibitor, for plaque psoriasis. By week 24, 46% of icotrokinra-treated patients achieved IGA 0 and 40% reached PASI 100.

Once-daily ICP-488 significantly improved PASI scores in patients with plaque psoriasis compared with placebo at week 12. The safety profile of ICP-488 was similar to placebo. ORLANDO — A once ...

Tildrakizumab showed sustained efficacy in plaque psoriasis, with nearly three years of mean drug survival across BSA severities and obesity categories. Patients experienced significant ...

(RTTNews) - Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO ...